IgG subclass levels in referred hemochromatosis probands with HFE p.C282Y/p.C282Y

James C. Barton; J. Clayborn Barton; Luigi F. Bertoli; Ronald T. Acton

doi:10.1371/journal.pone.0302817

Abstract

Background

IgG subclass levels in hemochromatosis are incompletely characterized.

Methods

We characterized IgG subclass levels of referred hemochromatosis probands with HFE p.C282Y/p.C282Y (rs1800562) and human leukocyte antigen (HLA)-A and -B typing/haplotyping and compared them with IgG subclass levels of eight published cohorts of adults unselected for hemochromatosis.

Results

There were 157 probands (82 men, 75 women; mean age 49±13 y). Median serum ferritin, mean body mass index (BMI), median IgG4, and median phlebotomy units to achieve iron depletion were significantly higher in men. Diabetes, cirrhosis, and HLA-A*03,-B*44, -A*03,B*07, and -A*01,B*08 prevalences and median absolute lymphocyte counts in men and women did not differ significantly. Mean IgG subclass levels [95% confidence interval] were: IgG1 5.31 g/L [3.04, 9.89]; IgG2 3.56 g/L [1.29, 5.75]; IgG3 0.61 g/L [0.17, 1.40]; and IgG4 0.26 g/L [<0.01, 1.25]. Relative IgG subclasses were 54.5%, 36.6%, 6.3%, and 2.7%, respectively. Median IgG4 was higher in men than women (0.34 g/L [0.01, 1.33] vs. 0.19 g/L [<0.01, 0.75], respectively; p = 0.0006). A correlation matrix with Bonferroni correction revealed the following positive correlations: IgG1 vs. IgG3 (p<0.01); IgG2 vs. IgG3 (p<0.05); and IgG2 vs. IgG4 (p<0.05). There was also a positive correlation of IgG4 vs. male sex (p<0.01). Mean IgG1 was lower and mean IgG2 was higher in probands than seven of eight published adult cohorts unselected for hemochromatosis diagnoses.

Conclusions

Mean IgG subclass levels of hemochromatosis probands were 5.31, 3.56, 0.61, and 0.26 g/L, respectively. Median IgG4 was higher in men than women. There were positive associations of IgG subclass levels. Mean IgG1 may be lower and mean IgG2 may be higher in hemochromatosis probands than adults unselected for hemochromatosis.

Citation: Barton JC, Barton JC, Bertoli LF, Acton RT (2024) IgG subclass levels in referred hemochromatosis probands with HFE p.C282Y/p.C282Y. PLoS ONE 19(5): e0302817. https://doi.org/10.1371/journal.pone.0302817

Editor: Andy Ka Chun Kan, The University of Hong Kong, HONG KONG

Received: July 1, 2023; Accepted: April 12, 2024; Published: May 14, 2024

Copyright: © 2024 Barton et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Data Availability: The dataset for the present analyses includes observations in the current 157 hemochromatosis probands and is available from Figshare at DOI: 10.6084/m9.figshare.23574933 (https://doi.org/10.6084/m9.figshare.23574933.v1).

Funding: The author(s) received no specific funding for this work.

Competing interests: The authors have declared that no competing interests exist.

Introduction

Hemochromatosis in whites of western European descent is associated with homozygosity for HFE p.C282Y (rs1800562), a common missense allele of the homeostatic iron regulator (chromosome 6p22.2) in linkage disequilibrium with human leukocyte antigen (HLA)-A*03 [1, 2]. HFE, a non-classical class I major histocompatibility complex (MHC) protein, is an upstream regulator of hepcidin and thus of iron homeostasis [3]. Laboratory phenotypes of many adults at diagnosis of hemochromatosis and p.C282Y/p.C282Y include elevated levels of transferrin saturation (TS) and serum ferritin (SF) [4]. Adults with p.C282Y/p.C282Y have increased risks of developing iron overload. Severe iron overload occurs predominantly in men [4, 5]. Non-HFE heritable and environmental variables modify iron loading in adults with hemochromatosis [2, 4, 6, 7]. Some adults with p.C282Y/p.C282Y also have hemochromatosis arthropathy, diabetes mellitus, hypogonadotropic hypogonadism, hepatic cirrhosis, or cardiomyopathy [4].

The prevalence of hemochromatosis TS/SF phenotypes and HFE p.C282Y homozygosity was significantly greater in 240 index patients with common variable immunodeficiency or immunoglobulin (Ig) G subclass deficiency than in 318 unrelated control subjects [8]. In a subsequent report, subnormal levels of IgG subclass 1 (IgG1), IgG3, or IgG1/IgG3 based on 1996 consensus guidelines [9] were common in 51 referred hemochromatosis probands with p.C282Y homozygosity [10] and there was concordance of Ig and hemochromatosis TS/SF phenotypes in probands and their HLA-identical siblings [10]. Thus, it was postulated that a putative allele on chromosome 6p haplotypes bearing either p.C282Y or HLA-A*03 influences IgG subclass levels [10].

Aims of this study are 1) to characterize serum IgG subclass levels at diagnosis in a replication cohort of 157 referred hemochromatosis probands with HFE p.C282Y homozygosity and HLA-A and -B typing/haplotyping, 2) to investigate laboratory and clinical associations with IgG subclass levels of this cohort, and 3) to compare mean and relative levels of IgG subclasses levels of this cohort with those of eight previously published adult cohorts unselected for hemochromatosis diagnoses. We discuss the present observations in the context of variables that influence IgG subclass levels of adults with and without diagnoses of hemochromatosis and p.C282Y homozygosity.

Methods

Ethics statement

This retrospective work was performed according to the principles of the Declaration of Helsinki [43]. Performance of this study was approved by Western Institutional Review Board, Inc. (submission 2539985–44189619). Western Institutional Review Board, Inc. waived the need for obtaining informed consent from participants in this study under United States Department of Health and Human Services, Office for Human Research Participants, regulation 45 CFR 46.101(b)(4). Obtaining informed consent was not required and thus was not obtained because this study involved retrospective chart review and analyses of observations recorded in routine medical care. Data analyzed in this study were not anonymized before the investigators accessed them because data were compiled from proband charts in an Alabama tertiary hematology center wherein JaCB and LFB diagnosed and treated all probands, consistent with Western Institutional Review Board, Inc. approval of this study. JaCB, JClB, and LFB had access to information that could identify individual probands during and after data collection. Data were accessed for research purposes during the interval 30 December 2018–3 June 2020. All data in this report are displayed in a manner that maintains proband anonymity in both the present results and corresponding dataset.

Subjects included

We retrospectively compiled data of all consecutive self-identified non-Hispanic whites aged ≥18 y referred to an Alabama tertiary hematology center during the study interval 1 January 2007–30 October 2018 for evaluation and management of hemochromatosis who met the following criteria: a) had HFE p.C282Y/p.C282Y, b) had no known non-hemochromatosis iron disorder, c) underwent measurement of IgG subclasses at diagnosis, d) underwent HLA-A and -B typing, e) achieved iron depletion with therapeutic phlebotomy, as appropriate, and f) were the first in their respective families to be diagnosed to have hemochromatosis (probands).

Medical histories were taken from probands and records of referring physicians. Referring physicians diagnosed and treated probands with diabetes. Physicians in the present hematology center evaluated probands for cirrhosis, as appropriate. All probands underwent medication review, physical examination, laboratory testing, imaging procedures, and evaluation of liver and other conditions, as indicated, before therapeutic phlebotomy was initiated [11].

Subjects excluded

We excluded probands with the following: a) hyperferritinemia, hemochromatosis, or HFE p.C282Y/p.C282Y diagnosed as a consequence of family or population screening, b) diagnosis of a primary or secondary hematologic disorder, c) volunteer whole-blood donation >two units in the year before hemochromatosis diagnosis, d) bariatric operation [12], e) viral hepatitis B or C, f) liver transplant, g) diagnosis of malignancy, h) anti-cancer therapy, i) non-iron-related chronic inflammatory condition, j) self-reported pregnancy, k) monoclonal or polyclonal gammopathy, or l) previous diagnosis of primary antibody deficiency.

We also excluded probands who reported current or recent therapy with any of the following medications previously associated with altered IgG or IgG subclass levels: a) hydroxychloroquine [13]; corticosteroids [14, 15]; captopril, carbamazepine, chloroquine, diphenylhydantoin, fenclofenac, gold compounds, hydantoin, levamisole, penicillamine, sulfasalazine, valproic acid, or zonisamide [16]; oxcarbazapine [17]; leflunomide [18], methotrexate [19], rituximab [20]; intravenous or subcutaneous polyclonal IgG [21]; or intravenous or subcutaneous monoclonal IgG.

Laboratory

Blood specimens were collected during mornings without regard to fasting. Complete blood counts were measured ≤1 h after diagnostic phlebotomy using an automated hematology analyzer (Cell-Dyn^® Model 610, Model 1700, Model 1800, or Emerald (Abbott Laboratories, Chicago, IL, USA)). Reference range for absolute lymphocyte count (ALC) was the same for each analyzer (0.6–4.1 x 10⁶/L). TS and SF were measured using standard methods (Laboratory Corporation of America, Burlington, NC, USA). We defined these TS and SF levels to be elevated: TS >50% (men) and TS >45% (women); and SF >300 μg/L (men) and SF >200 μg/L (women) [22, 23].

Serum IgG and IgG subclass levels at diagnosis were measured using rate nephelometry (Laboratory Corporation of America, Burlington, NC, USA). The following previously suggested reference limits were based on 1996 consensus guidelines [9]: IgG 7.00–16.00 g/L (700–1600 mg/dL); IgG1 4.22–12.92 g/L (422–1292 mg/dL); IgG2 1.17–7.47 g/L (117–747 mg/dL); IgG3 0.41–1.29 g/L (41–129 mg/dL); and IgG4 0.01–2.91 g/L (1–291 mg/dL) (Laboratory Corporation of America, Burlington, NC, USA).

HFE genotyping was performed as previously described [24]. We determined HLA-A and -B types and haplotypes as previously described [24, 25]. We studied HLA-A*03, the optimal marker for the hemochromatosis ancestral haplotype [24], and HLA-A*03, B*07, the most common HLA-A and -B haplotype in p.C282Y homozygotes [25]. We also studied two other markers, prevalences of which are increased in adults with subnormal IgG subclass levels and frequent/severe respiratory tract infection: HLA-B*44 [15, 26, 27] and HLA-A*01, B*08 [15, 26]. Positivity for HLA types and haplotypes was defined as either homozygosity or heterozygosity.

Iron removed to achieve iron depletion

Iron depletion therapy, defined as the periodic removal of blood to eliminate storage iron, was performed in all probands with elevated SF levels (>300 μg/L (men) and >200 μg/L (women)) as described elsewhere [28]. We defined 450–500 mL of blood removed at a single phlebotomy session as one unit. Iron depletion therapy was complete when SF was ≤20 μg/L [28]. We defined the number of units of blood removed to achieve iron depletion in probands without elevated SF as zero.

IgG subclasses in previously reported adult cohorts

We performed computerized and manual searches to identify representative reports of IgG subclass levels of cohorts of >50 adults. We selected cohorts for tabulation based on study population, methodology used to quantify IgG subclass levels, and computation and display of mean IgG subclass levels.

Statistics

We evaluated the medical records of 169 referred probands and excluded 12 (7.1%; three with viral hepatitis B or C, three with polyclonal gammopathy, two with monoclonal gammopathy, and four with insufficient data). The dataset for the present analyses includes observations in the remaining 157 hemochromatosis probands and is available in Figshare repository [29]. TS measures before phlebotomy treatment commenced were unavailable in six of 157 probands (3.8%; three men, three women) [29]. Seven of 157 probands (4.5%; six men, one woman) did not complete phlebotomy to achieve iron depletion [29]. Thus, TS and therapeutic phlebotomy data are reported herein for 151 probands and 150 probands, respectively [29].

We display age, TS, and SF data as integers, body mass index (BMI), ALC, and phlebotomy units to achieve iron depletion data with one significant decimal place, and IgG subclass data with two or three significant figures. IgG4 levels reported as <0.01 g/L were imputed as 0.005 g/L. We excluded total IgG measures from most analyses because IgG levels of adults are determined predominantly by IgG1 and IgG2 levels [30, 31]. We compared 15 characteristics of the previous cohort of 51 hemochromatosis probands [10] with those of the present replication cohort of 157 hemochromatosis probands.

Frequency distributions of IgG subclass levels, displayed as smoothed curves, depict percentages of 157 probands as functions of ten subgroups of the corresponding IgG subclass levels. Error bars represent 95% confidence intervals (CI) for the proportions of probands in each of the ten subgroups. We defined IgG subclass levels <2 SD below the corresponding means as subnormal.

Kolmogorov-Smirnov testing demonstrated that age and BMI data did not differ significantly from those which are normally distributed. We displayed these data as means ± 1 standard deviation (SD) and compared them using Student’s t test for unpaired data (two-tailed). TS, SF, ALC, and phlebotomy units to achieve iron depletion data differed significantly from those which are normally distributed. We displayed these data as medians (range) and compared them using Mann-Whitney U test (two-tailed). In other analyses, we used ln transformations to adjust IgG subclass data to Gaussian distributions. Means of IgG subclass levels, 95% CI, and percentiles (2.5, 5, 10, 25, 50, 75, 90, 95, 97.5) were determined from the means and SDs of the natural logarithm (ln) data and transformed as anti-ln values to the original scale for presentation. Categorical variables were compared using Fisher’s exact test (two-tailed).

To identify relationships of IgG subclass values with other variables, we computed a correlation matrix with Bonferroni corrections on the variables sex, age, TS, SF, BMI, IgG subclass levels, and positivity for A*03 and B*44.

We used Excel^® 2000 (Microsoft Corp., Redmond, WA, USA) and GraphPad Prism 8^® (2018; GraphPad Software, San Diego, CA, USA). We defined p <0.05 to be significant, although we used Bonferroni corrections to reduce the likelihood of type I errors in multiple univariate and bivariate comparisons.

Results

Validation of a replicate hemochromatosis proband cohort

We compared 15 characteristics of a 2003 hemochromatosis proband cohort (n = 51) [10] with those of the present probands (n = 157) (Table 1). Comparisons revealed no significant differences between these cohorts after Bonferroni correction, demonstrating that the present cohort of 157 probands is a replicate of the 2003 cohort.

Download:

Table 1. Two cohorts of referred hemochromatosis probands with HFE p.C282Y/p.C282Y^{^a}.

https://doi.org/10.1371/journal.pone.0302817.t001

Characteristics of 157 referred hemochromatosis probands

There were 82 men (52.2%) and 75 women (47.8%) (Table 2). TS was elevated in 75 men (91.5%) and 66 women (88.0%) (p = 0.5995). SF was elevated in 72 men (91.5%) and 64 women (85.3%) (p = 0.8150). After Bonferroni correction, median SF, mean BMI, mean IgG4, and median phlebotomy units to achieve iron depletion were significantly higher in men than women (Table 2).

Download:

Table 2. Referred probands with hemochromatosis and HFE p.C282Y/p.C282Y^{^a}.

https://doi.org/10.1371/journal.pone.0302817.t002

Frequency distributions of IgG subclass levels

The highest prevalence of IgG1 levels occurred in the range 4.22–5.33 g/L (Fig 1). The highest prevalence of IgG2 levels occurred in the range 2.61–3.32 g/L (Fig 2). The highest prevalence of IgG3 levels occurred in the range 0.71–0.85 g/L (Fig 3). The highest prevalence of IgG4 levels occurred in the range 0.01–0.17 g/L (Fig 4). Frequency distributions of all IgG subclass levels were right skewed. Ratios of the highest: lowest levels of respective IgG subclass levels were the following: IgG1 = 4.9: 1; IgG2 = 7.5: 1; IgG3 = 11.2: 1; and IgG4 = 282.1: 1. Pearson’s correlation of ln (IgG1+IgG2+IgG3+IgG4) vs. ln total IgG was strong (r = 0.9274; p <0.0001).

Download:

Fig 1. Smoothed frequency distribution of serum IgG1 subclass levels of 157 hemochromatosis probands with HFE p.C282Y homozygosity.

Error bars represent 95% confidence intervals of proband percentages with continuity corrections.

https://doi.org/10.1371/journal.pone.0302817.g001

Download:

Fig 2. Smoothed frequency distribution of serum IgG2 subclass levels of 157 hemochromatosis probands with HFE p.C282Y homozygosity.

Error bars represent 95% confidence intervals of proband percentages with continuity corrections.

https://doi.org/10.1371/journal.pone.0302817.g002

Download:

Fig 3. Smoothed frequency distribution of serum IgG3 subclass levels of 157 hemochromatosis probands with HFE p.C282Y homozygosity.

Error bars represent 95% confidence intervals of proband percentages with continuity corrections.

https://doi.org/10.1371/journal.pone.0302817.g003

Download:

Fig 4. Smoothed frequency distribution of serum IgG4 subclass levels of 157 hemochromatosis probands with HFE p.C282Y homozygosity.

Error bars represent 95% confidence intervals of proband percentages with continuity corrections.

https://doi.org/10.1371/journal.pone.0302817.g004

Percentiles of IgG subclass levels

The respective percentile values of IgG1, IgG2, and IgG3 levels were similar in men and women. All percentile values of IgG4 levels were lower in women than men (Table 3).

Download:

Table 3. Percentiles of IgG subclass levels in referred hemochromatosis probands with HFE p.C282Y/p.C282Y.

https://doi.org/10.1371/journal.pone.0302817.t003

Correlations of IgG subclass levels

We computed a correlation matrix (with Bonferroni corrections) on the variables sex, age, TS, SF, BMI, IgG subclass levels, and positivity for A*03 and B*44. This revealed the following positive correlations: IgG1 vs. IgG3 (p<0.01); IgG2 vs. IgG3 (p <0.05); and IgG2 vs. IgG4 (p <0.05). There was also a positive correlation of IgG4 vs. male sex (p <0.01).

IgG subclass levels of adults with and without hemochromatosis diagnoses

Mean IgG subclass levels [95% CI] of 157 probands were: IgG1 5.31 g/L [3.04, 9.89]; IgG2 3.56 g/L [1.29, 5.75]; IgG3 0.61 g/L [0.17, 1.40]; and IgG4 0.26 g/L [<0.01, 1.25]. Relative levels of IgG1, IgG2, IgG3, and IgG4 were 54.5%, 36.6%, 6.3%, and 2.7%, respectively (Table 4). We defined IgG subclass levels <2 SD below the corresponding means as subnormal. In the present cohort of 157 hemochromatosis probands, subnormal IgG1, IgG2, IgG3, and IgG4 levels were defined as <3.04 g/L, <1.29 g/L, <0.17 g/L, and <0.01 g/L, respectively.

Download:

Table 4. Serum IgG subclass levels of adults.

https://doi.org/10.1371/journal.pone.0302817.t004

Mean and relative levels of IgG subclasses of the present and of eight previously published adult cohorts (n >50) without hemochromatosis diagnoses are displayed in Table 4. Mean IgG1 level of the present cohort was lower than that of seven of the eight other cohorts. Mean IgG2 level of the present cohort was higher than that of seven of the eight other cohorts. Mean IgG3 level of the present cohort was lower than that of three other cohorts. Mean IgG4 level of the present cohort was lower than that of five other cohorts.

Relative IgG1 level of the present cohort was lower than that of eight other cohorts (Table 4). Relative IgG2 level of the present cohort was higher than that of eight other cohorts. Relative IgG3 level of the present cohort was lower than that of two other cohorts. Relative IgG4 level of the present cohort was lower than that five other cohorts.

Discussion

A novel feature of the present study is characterization of serum IgG subclass levels of a replication cohort of 157 referred adult hemochromatosis probands with HFE p.C282Y homozygosity without non-hemochromatosis iron-related disorders or conditions or treatments often associated with abnormal IgG or IgG subclass levels. Median SF, mean BMI, median IgG4, and median phlebotomy units to achieve iron depletion were significantly higher in men than women, typical of adults referred with hemochromatosis [4]. We compared IgG subclass data in the present cohort with those of eight previously published adult cohorts unselected for hemochromatosis diagnoses [32–39].

We observed no significant differences in corresponding IgG1 and IgG2 levels of men and women with hemochromatosis, in agreement with four studies of adults unselected for hemochromatosis diagnoses [35, 36, 38, 39]. Median IgG3 levels of the present men and women did not differ significantly, consistent with a previous report [36], whereas mean IgG3 level of women was 1.2-fold higher than that of men in another study [35]. IgG4 levels were significantly higher in the present men than women. In four other studies, mean IgG4 in men was also significantly higher than that of women [35, 36, 39]. No significant differences between IgG subclass levels of men and women were detected in a study of 68 healthy blood donors [38].

In this study, IgG subclass levels were not significantly associated with TS or phlebotomy units of blood removed to achieve iron depletion. These findings agree with observations in a 2003 cohort of hemochromatosis probands with HFE p.C282Y homozygosity [10]. In another study, mean IgG levels of non-pregnant Iranian women with and without iron deficiency did not differ significantly [40]. In Chinese children, mean IgG1 and IgG4 levels were significantly lower in those with than without iron deficiency [41].

IgG1 levels were positively associated with IgG3 levels in this study. Fifteen of the present probands (9.6%) had both IgG1 <4.21 g/L and IgG3 <0.41 g/L at diagnosis. IGHG1 and IGHG3 loci, adjacent on chromosome 14q32.33, are in linkage disequilibrium [42]. Antibody responses to soluble and membrane proteins primarily induce IgG1, although lower levels of IgG3 and IgG4 responses to protein antigens also occur [43]. There is a significant positive association of IgG1 and IgG3 levels of adults unselected for hemochromatosis or antibody deficiency diagnoses [44] and subnormal levels of both IgG1 and IgG3 are common in adults with frequent or severe respiratory tract infection [15, 45].

IgG2 levels were positively associated with IgG4 levels in the present study. IGHG2 and IGHG4 loci are adjacent on chromosome 14q32.33 [42]. Mean levels of IgG2 and IgG4 are higher in subjects positive rather than negative for the genetic marker Gm(23) [44]. Subnormal levels of IgG2 often occur in association with subnormal IgG4 levels [46].

IgG3 levels were positively associated with IgG1 levels in this study. Subnormal IgG3 levels are often associated with subnormal levels of other IgG subclasses in adults unselected for hemochromatosis diagnoses [31, 45].

IgG1, IgG2, IgG3, and IgG4 levels were not significantly associated with HLA-A*03 positivity or HLA-B*44 positivity, after adjustment for other variables. In Alabama and Portugal hemochromatosis patients with HFE p.C282Y homozygosity and positivity for a 500 kb microhaplotype GGG defined by SNPs in chromosome 6p genes PGBD1, ZNF193, and ZNF165 [47], IgG3 levels were significantly higher than those of patients homozygous for microhaplotype AAT that is strongly associated with HLA-A*03 [48]. In contrast, IgG1, IgG2, and IgG4 levels did not differ significantly in patients with or without GGG [48]. This suggests that a chromosome 6p locus linked to GGG increases IgG3 levels, consistent with a previous postulate [10]. We found no other report that rs1800562 or HFE is associated with IgG subclass levels of humans [49].

In the present cohort, subnormal IgG1, IgG2, IgG3, and IgG4 levels were <3.04 g/L, <1.29 g/L, <0.17 g/L, and <0.01 g/L, respectively. The mean level of IgG1 was lower in the present cohort than in seven of eight previously published cohorts unselected for hemochromatosis [32–39]. The mean level of IgG2 was higher in the present cohort than in seven of eight published cohorts unselected for hemochromatosis [32–39]. These comparisons suggest that IgG subclass levels of referred hemochromatosis probands with HFE p.C282Y homozygosity differ from those of adults unselected for hemochromatosis diagnoses. It is plausible although unproven that rates of IgG subclass synthesis or catabolism differ in adults with and without p.C282Y homozygosity. HFE RNA expression is low in naive and memory B-lymphocytes and myeloma cell lines [50], although it is unreported whether RNA expression differs in these respective cells with and without p.C282Y/p.C282Y. Differences in study populations, collection, handling, and storage of sera, and methodology, reagents, and instrumentation used to measure IgG subclasses across cohorts we tabulated could also contribute to these differences.

Strengths of this study include evaluation of a large cohort of referred adult hemochromatosis probands with HFE p.C282Y homozygosity with HLA-A and -B typing/haplotyping without non-hemochromatosis iron-related disorders or conditions or treatments often associated with abnormal IgG or IgG subclass levels. A limitation of this study is the lack of IgG subclass observations in control cohorts of age- and sex-matched adults with p.C282Y homozygosity identified in population screening and adults with HFE wt/wt (lack of p.C282Y and p.H63D (rs1799945)).

The present cohort consisted of non-Hispanic whites. We compared their IgG subclass levels with those in other cohorts that were or presumed to be predominantly white subjects of European descent. Nonetheless, IgG subclass concentrations differ according to race [39]. It is also plausible although unproven that IgG subclass values may differ across non-Hispanic whites of different European ethnicities, nationalities, or derivative countries.

A single clinical laboratory measured all IgG subclasses we report, although it is improbable that the same reagents and instrumentation were used throughout the interval of the present study. Further, it is likely that variables other than those we studied are major determinants of IgG subclass levels. MHC class II typing, chromosome 6p microhaplotyping, detection of IgG subclass alleles, and measurement of specific antibodies and responsiveness to specific antigens were beyond the scope of this study.

Conclusions

Mean IgG subclass levels of hemochromatosis probands were 5.31, 3.56, 0.61, and 0.26 g/L, respectively. Median IgG4 was higher in men than women. There were positive associations of IgG subclass levels. Mean IgG1 may be lower and IgG2 may be higher in hemochromatosis probands than adults unselected for hemochromatosis.

References

1. Feder JN, Gnirke A, Thomas W, Tsuchihashi Z, Ruddy DA, Basava A, et al. A novel MHC class I-like gene is mutated in patients with hereditary haemochromatosis. Nat Genet. 1996;13: 399–408. pmid:8696333
- View Article
- PubMed/NCBI
- Google Scholar
2. Barton JC, Edwards CQ, Acton RT. HFE gene: Structure, function, mutations, and associated iron abnormalities. Gene. 2015;574: 179–192.
- View Article
- Google Scholar
3. Rishi G, Wallace DF, Subramaniam VN. Hepcidin: regulation of the master iron regulator. Biosci Rep. 2015;35: e00192. pmid:26182354
- View Article
- PubMed/NCBI
- Google Scholar
4. Edwards CQ, Barton JC. Hemochromatosis. In: Greer JP, Rodgers GM, Glader B, Arber DA, Means RT Jr, et al., editors. Wintrobe’s Clinical Hematology. Philadelphia: Wolters Kluwer; 2019. pp. 665–690.
5. Barton JC, McLaren CE, Chen WP, Ramm GA, Anderson GJ, Powell LW, et al. Cirrhosis in hemochromatosis: independent risk factors in 368 HFE p.C282Y homozygotes. Ann Hepatol. 2018;17: 871–879.
- View Article
- Google Scholar
6. Wood MJ, Powell LW, Ramm GA. Environmental and genetic modifiers of the progression to fibrosis and cirrhosis in hemochromatosis. Blood. 2008;111: 4456–4462. pmid:18316631
- View Article
- PubMed/NCBI
- Google Scholar
7. Martin M, Millan A, Ferraro F, Tetzlaff WF, Lozano CE, Botta E, et al. Leukocyte telomere length is associated with iron overload in male adults with hereditary hemochromatosis. Biosci Rep. 2020;40. pmid:33026063
- View Article
- PubMed/NCBI
- Google Scholar
8. Barton JC, Bertoli LF, Acton RT (2000) Hemochromatosis and primary antibody deficiency: occurrence in the same individual and frequency of common HFE mutations among common variable immunodeficiency and Ig subclass index cases. Blood. 96: 4b.
- View Article
- Google Scholar
9. Dati F, Schumann G, Thomas L, Aguzzi F, Baudner S, Bienvenu J, et al. Consensus of a group of professional societies and diagnostic companies on guidelines for interim reference ranges for 14 proteins in serum based on the standardization against the IFCC/BCR/CAP Reference Material (CRM 470). International Federation of Clinical Chemistry. Community Bureau of Reference of the Commission of the European Communities. College of American Pathologists. Eur J Clin Chem Clin Biochem. 1996;34: 517–520. pmid:8831057
- View Article
- PubMed/NCBI
- Google Scholar
10. Barton JC, Bertoli LF, Acton RT. Common variable immunodeficiency and IgG subclass deficiency in central Alabama hemochromatosis probands homozygous for HFE C282Y. Blood Cells Mol Dis. 2003;31: 102–111.
- View Article
- Google Scholar
11. Barton JC, Barton JC, Acton RT. Non-alcoholic fatty liver disease in hemochromatosis probands with iron overload and HFE p.C282Y/p.C282Y. BMC Gastroenterology. 2023;23: 137.
- View Article
- Google Scholar
12. Barton JC. Hemochromatosis, HFE C282Y homozygosity, and bariatric surgery: report of three cases. Obes Surg. 2004;14: 1409–1414.
- View Article
- Google Scholar
13. Barton JC, Barton JC, Bertoli LF. Hydroxychloroquine therapy and serum immunoglobulin levels in women with IgG subclass deficiency and systemic lupus erythematosus, Sjögren syndrome, and rheumatoid arthritis: a retrospective study. Arch Immunol Ther Exp (Warsz). 2022;70: 14.
- View Article
- Google Scholar
14. Barton JC, Bertoli LF, Barton JC, Acton RT. Selective subnormal IgG3 in 121 adult index patients with frequent or severe bacterial respiratory tract infections. Cell Immunol. 2016;299: 50–57. pmid:26410396
- View Article
- PubMed/NCBI
- Google Scholar
15. Barton JC, Barton JC, Bertoli LF, Acton RT. HLA-A and -B type and haplotype frequencies in IgG subclass deficiency subgroups. Arch Immunol Ther Exp (Warsz). 2020;68: 14. pmid:32307610
- View Article
- PubMed/NCBI
- Google Scholar
16. Vorechovsky I, Cullen M, Carrington M, Hammarstrom L, Webster AD. Fine mapping of IGAD1 in IgA deficiency and common variable immunodeficiency: identification and characterization of haplotypes shared by affected members of 101 multiple-case families. J Immunol. 2000;164: 4408–4416.
- View Article
- Google Scholar
17. Knight AK, Cunningham-Rundles C. Oxcarbazepine-induced immunoglobulin deficiency. Clin Diagn Lab Immunol. 2005;12: 560–561. pmid:15817769
- View Article
- PubMed/NCBI
- Google Scholar
18. Siemasko K, Chong AS, Jack HM, Gong H, Williams JW, Finnegan A. Inhibition of JAK3 and STAT6 tyrosine phosphorylation by the immunosuppressive drug leflunomide leads to a block in IgG1 production. J Immunol. 1998;160: 1581–1588. pmid:9469413
- View Article
- PubMed/NCBI
- Google Scholar
19. Rackham OJ, Sills JA, Davidson JE. Immunoglobulin levels in methotrexate treated paediatric rheumatology patients. Arch Dis Child. 2002;87: 147–148. pmid:12138068
- View Article
- PubMed/NCBI
- Google Scholar
20. Marcinno A, Marnetto F, Valentino P, Martire S, Balbo A, Drago A, et al. Rituximab-induced hypogammaglobulinemia in patients with neuromyelitis optica spectrum disorders. Neurol Neuroimmunol Neuroinflamm. 2018;5: e498. pmid:30258855
- View Article
- PubMed/NCBI
- Google Scholar
21. Mahmood I, Tegenge MA, Golding B. Considerations for optimizing dosing of immunoglobulins based on pharmacokinetic evidence. Antibodies (Basel). 2020;9. pmid:32575458
- View Article
- PubMed/NCBI
- Google Scholar
22. Adams PC, Reboussin DM, Barton JC, McLaren CE, Eckfeldt JH, McLaren GD, et al. Hemochromatosis and iron-overload screening in a racially diverse population. N Engl J Med. 2005;352: 1769–1778. pmid:15858186
- View Article
- PubMed/NCBI
- Google Scholar
23. Barton JC, Acton RT, Dawkins FW, Adams PC, Lovato L, Leiendecker-Foster C, et al. Initial screening transferrin saturation values, serum ferritin concentrations, and HFE genotypes in whites and blacks in the Hemochromatosis and Iron Overload Screening Study. Genet Test. 2005;9: 231–241.
- View Article
- Google Scholar
24. Barton JC, Barton JC, Acton RT. HLA-A*03, the hemochromatosis ancestral haplotype, and phenotypes of referred hemochromatosis probands with HFE p.C282Y homozygosity. Hereditas. 2022;159: 25.
- View Article
- Google Scholar
25. Barton JC, Acton RT. HLA-A and -B alleles and haplotypes in hemochromatosis probands with HFE C282Y homozygosity in central Alabama. BMC Med Genet. 2002;3: 9.
- View Article
- Google Scholar
26. Barton JC, Bertoli LF, Acton RT. HLA-A and -B alleles and haplotypes in 240 index patients with common variable immunodeficiency and selective IgG subclass deficiency in central Alabama. BMC Med Genet. 2003;4: 3. pmid:12803653
- View Article
- PubMed/NCBI
- Google Scholar
27. Johnston DT, Mehaffey G, Thomas J, Young KR Jr., Wiener H, Li J, et al. Increased frequency of HLA-B44 in recurrent sinopulmonary infections (RESPI). Clin Immunol. 2006;119: 346–350. pmid:16542878
- View Article
- PubMed/NCBI
- Google Scholar
28. Adams PC, Barton JC. How I treat hemochromatosis. Blood. 2010;116: 317–325. pmid:20308595
- View Article
- PubMed/NCBI
- Google Scholar
29. Barton JC, Barton JC, Bertoli LF, Acton RT. Dataset: IgG subclasses in 157 referred hemochromatosis probands with HFE p.C282Y homozygosity; 6-24-2023 [cited 6-24-2023]. https://figshare.com/account/items/23574933/edit
30. Vidarsson G, Dekkers G, Rispens T. IgG subclasses and allotypes: from structure to effector functions. Front Immunol. 2014;5: 520. pmid:25368619
- View Article
- PubMed/NCBI
- Google Scholar
31. Barton JC, Barton JC, Bertoli LF, Acton RT. Factors associated with IgG levels in adults with IgG subclass deficiency. BMC Immunol. 2021;22: 53. pmid:34372773
- View Article
- PubMed/NCBI
- Google Scholar
32. Morrell A, Skvaril F, Steinberg AG, van Loghem E, Terry WD. Correlations between the concentrations of the four sub-classes of IgG and Gm allotypes in normal human sera. J Immunol. 2023;108: 195–206.
- View Article
- Google Scholar
33. van der Giessen M, Rossouw E, van Veen TA, van L E, Zegers BJ, Sander PC. Quantification of IgG subclasses in sera of normal adults and healthy children between 4 and 12 years of age. Clin Exp Immunol. 1975;21: 501–509. pmid:54236
- View Article
- PubMed/NCBI
- Google Scholar
34. Shakib F, Stanworth DR, Drew R, Catty D. A quantitative study of the distribution of IgG sub-classes in a group of normal human sera. J Immunol Methods. 1975;8: 17–28. pmid:807655
- View Article
- PubMed/NCBI
- Google Scholar
35. French MA, Harrison G. Serum IgG subclass concentrations in healthy adults: a study using monoclonal antisera. Clin Exp Immunol. 1984;56: 473–475. pmid:6733979
- View Article
- PubMed/NCBI
- Google Scholar
36. Aucouturier P, Mounir S, Preud’homme JL. Distribution of IgG subclass levels in normal adult sera as determined by a competitive enzyme immunoassay using monoclonal antibodies. Diagn Immunol. 1985;3: 191–196. pmid:4085174
- View Article
- PubMed/NCBI
- Google Scholar
37. Madassery JV, Kwon OH, Lee SY, Nahm MH. IgG2 subclass deficiency: IgG subclass assays and IgG2 concentrations among 8015 blood donors. Clin Chem. 1988;34: 1407–1413. pmid:3292083
- View Article
- PubMed/NCBI
- Google Scholar
38. Schauer U, Stemberg F, Rieger CH, Borte M, Schubert S, Riedel F, et al. IgG subclass concentrations in certified reference material 470 and reference values for children and adults determined with the binding site reagents. Clin Chem. 2003;49: 1924–1929. pmid:14578325
- View Article
- PubMed/NCBI
- Google Scholar
39. Harkness T, Fu X, Zhang Y, Choi HK, Stone JH, Blumenthal KG, et al. Immunoglobulin G and immunoglobulin G subclass concentrations differ according to sex and race. Ann Allergy Asthma Immunol. 2020;125: 190–195. pmid:32224206
- View Article
- PubMed/NCBI
- Google Scholar
40. Sadeghian MH, Keramati MR, Ayatollahi H, Manavifar L, Enaiati H, Mahmoudi M. Serum immunoglobulins in patients with iron deficiency anemia. Indian J Hematol Blood Transfus. 2010;26: 45–48. pmid:21629635
- View Article
- PubMed/NCBI
- Google Scholar
41. Feng XB, Yang XQ, Shen J. Influence of iron deficiency on serum IgG subclass and pneumococcal polysaccharides specific IgG subclass antibodies. Chin Med J (Engl). 1994;107: 813–816. pmid:7867386
- View Article
- PubMed/NCBI
- Google Scholar
42. Bashirova AA, Zheng W, Akdag M, Augusto DG, Vince N, Dong KL, et al. Population-specific diversity of the immunoglobulin constant heavy G chain (IGHG) genes. Genes Immun. 2021;22: 327–334. pmid:34864821
- View Article
- PubMed/NCBI
- Google Scholar
43. Ferrante A, Beard LJ, Feldman RG. IgG subclass distribution of antibodies to bacterial and viral antigens. Pediatr Infect Dis J. 1990;9: S16–S24. pmid:2216603
- View Article
- PubMed/NCBI
- Google Scholar
44. Morell A, Skvaril F, Steinberg AG, van L E, Terry WD. Correlations between the concentrations of the four sub-classes of IgG and Gm allotypes in normal human sera. J Immunol. 1972;108: 195–206. pmid:4622006
- View Article
- PubMed/NCBI
- Google Scholar
45. Khokar A, Gupta S. Clinical and immunological features of 78 adult patients with primary selective IgG subclass deficiencies. Arch Immunol Ther Exp (Warsz). 2019;67: 325–334. pmid:31363786
- View Article
- PubMed/NCBI
- Google Scholar
46. Latiff AH, Kerr MA. The clinical significance of immunoglobulin A deficiency. Ann Clin Biochem. 2007;44: 131–139. pmid:17362578
- View Article
- PubMed/NCBI
- Google Scholar
47. Costa M, Cruz E, Barton JC, Thorstensen K, Morais S, da Silva BM, et al. Effects of highly conserved major histocompatibility complex (MHC) extended haplotypes on iron and low CD8+ T lymphocyte phenotypes in HFE C282Y homozygous hemochromatosis patients from three geographically distant areas. PLoS One. 2013;8: e79990.
- View Article
- Google Scholar
48. Barton JC, Barton JC, Cruz E, Teles MJ, Guimaraes JT, Porto G. Chromosome 6p SNP microhaplotypes and IgG3 levels in hemochromatosis probands with HFE p.C282Y homozygosity. Blood Cells Mol Dis. 2020;85: 102461.
- View Article
- Google Scholar
49. National Human Genome Research Institute and European Bioinformatics Institute. GWAS Catalog. The NHGRI-EBI Catalog of human genome-wide association studies; 5-20-2023 [cited 6-2-2023]. https://www.ebi.ac.uk/gwas/search?query
50. proteinatlas.org. The Human Protein Atlas. HFE; 2023 [cited 6-23-2023]. https://www.proteinatlas.org/ENSG00000010704-HFE

[ref1] 1. Feder JN, Gnirke A, Thomas W, Tsuchihashi Z, Ruddy DA, Basava A, et al. A novel MHC class I-like gene is mutated in patients with hereditary haemochromatosis. Nat Genet. 1996;13: 399–408. pmid:8696333
View Article
PubMed/NCBI
Google Scholar

[2] View Article

[3] PubMed/NCBI

[4] Google Scholar

[ref2] 2. Barton JC, Edwards CQ, Acton RT. HFE gene: Structure, function, mutations, and associated iron abnormalities. Gene. 2015;574: 179–192.
View Article
Google Scholar

[6] View Article

[7] Google Scholar

[ref3] 3. Rishi G, Wallace DF, Subramaniam VN. Hepcidin: regulation of the master iron regulator. Biosci Rep. 2015;35: e00192. pmid:26182354
View Article
PubMed/NCBI
Google Scholar

[9] View Article

[10] PubMed/NCBI

[11] Google Scholar

[ref4] 4. Edwards CQ, Barton JC. Hemochromatosis. In: Greer JP, Rodgers GM, Glader B, Arber DA, Means RT Jr, et al., editors. Wintrobe’s Clinical Hematology. Philadelphia: Wolters Kluwer; 2019. pp. 665–690.

[ref5] 5. Barton JC, McLaren CE, Chen WP, Ramm GA, Anderson GJ, Powell LW, et al. Cirrhosis in hemochromatosis: independent risk factors in 368 HFE p.C282Y homozygotes. Ann Hepatol. 2018;17: 871–879.
View Article
Google Scholar

[14] View Article

[15] Google Scholar

[ref6] 6. Wood MJ, Powell LW, Ramm GA. Environmental and genetic modifiers of the progression to fibrosis and cirrhosis in hemochromatosis. Blood. 2008;111: 4456–4462. pmid:18316631
View Article
PubMed/NCBI
Google Scholar

[17] View Article

[18] PubMed/NCBI

[19] Google Scholar

[ref7] 7. Martin M, Millan A, Ferraro F, Tetzlaff WF, Lozano CE, Botta E, et al. Leukocyte telomere length is associated with iron overload in male adults with hereditary hemochromatosis. Biosci Rep. 2020;40. pmid:33026063
View Article
PubMed/NCBI
Google Scholar

[21] View Article

[22] PubMed/NCBI

[23] Google Scholar

[ref8] 8. Barton JC, Bertoli LF, Acton RT (2000) Hemochromatosis and primary antibody deficiency: occurrence in the same individual and frequency of common HFE mutations among common variable immunodeficiency and Ig subclass index cases. Blood. 96: 4b.
View Article
Google Scholar

[25] View Article

[26] Google Scholar

[ref9] 9. Dati F, Schumann G, Thomas L, Aguzzi F, Baudner S, Bienvenu J, et al. Consensus of a group of professional societies and diagnostic companies on guidelines for interim reference ranges for 14 proteins in serum based on the standardization against the IFCC/BCR/CAP Reference Material (CRM 470). International Federation of Clinical Chemistry. Community Bureau of Reference of the Commission of the European Communities. College of American Pathologists. Eur J Clin Chem Clin Biochem. 1996;34: 517–520. pmid:8831057
View Article
PubMed/NCBI
Google Scholar

[28] View Article

[29] PubMed/NCBI

[30] Google Scholar

[ref10] 10. Barton JC, Bertoli LF, Acton RT. Common variable immunodeficiency and IgG subclass deficiency in central Alabama hemochromatosis probands homozygous for HFE C282Y. Blood Cells Mol Dis. 2003;31: 102–111.
View Article
Google Scholar

[32] View Article

[33] Google Scholar

[ref11] 11. Barton JC, Barton JC, Acton RT. Non-alcoholic fatty liver disease in hemochromatosis probands with iron overload and HFE p.C282Y/p.C282Y. BMC Gastroenterology. 2023;23: 137.
View Article
Google Scholar

[35] View Article

[36] Google Scholar

[ref12] 12. Barton JC. Hemochromatosis, HFE C282Y homozygosity, and bariatric surgery: report of three cases. Obes Surg. 2004;14: 1409–1414.
View Article
Google Scholar

[38] View Article

[39] Google Scholar

[ref13] 13. Barton JC, Barton JC, Bertoli LF. Hydroxychloroquine therapy and serum immunoglobulin levels in women with IgG subclass deficiency and systemic lupus erythematosus, Sjögren syndrome, and rheumatoid arthritis: a retrospective study. Arch Immunol Ther Exp (Warsz). 2022;70: 14.
View Article
Google Scholar

[41] View Article

[42] Google Scholar

[ref14] 14. Barton JC, Bertoli LF, Barton JC, Acton RT. Selective subnormal IgG3 in 121 adult index patients with frequent or severe bacterial respiratory tract infections. Cell Immunol. 2016;299: 50–57. pmid:26410396
View Article
PubMed/NCBI
Google Scholar

[44] View Article

[45] PubMed/NCBI

[46] Google Scholar

[ref15] 15. Barton JC, Barton JC, Bertoli LF, Acton RT. HLA-A and -B type and haplotype frequencies in IgG subclass deficiency subgroups. Arch Immunol Ther Exp (Warsz). 2020;68: 14. pmid:32307610
View Article
PubMed/NCBI
Google Scholar

[48] View Article

[49] PubMed/NCBI

[50] Google Scholar

[ref16] 16. Vorechovsky I, Cullen M, Carrington M, Hammarstrom L, Webster AD. Fine mapping of IGAD1 in IgA deficiency and common variable immunodeficiency: identification and characterization of haplotypes shared by affected members of 101 multiple-case families. J Immunol. 2000;164: 4408–4416.
View Article
Google Scholar

[52] View Article

[53] Google Scholar

[ref17] 17. Knight AK, Cunningham-Rundles C. Oxcarbazepine-induced immunoglobulin deficiency. Clin Diagn Lab Immunol. 2005;12: 560–561. pmid:15817769
View Article
PubMed/NCBI
Google Scholar

[55] View Article

[56] PubMed/NCBI

[57] Google Scholar

[ref18] 18. Siemasko K, Chong AS, Jack HM, Gong H, Williams JW, Finnegan A. Inhibition of JAK3 and STAT6 tyrosine phosphorylation by the immunosuppressive drug leflunomide leads to a block in IgG1 production. J Immunol. 1998;160: 1581–1588. pmid:9469413
View Article
PubMed/NCBI
Google Scholar

[59] View Article

[60] PubMed/NCBI

[61] Google Scholar

[ref19] 19. Rackham OJ, Sills JA, Davidson JE. Immunoglobulin levels in methotrexate treated paediatric rheumatology patients. Arch Dis Child. 2002;87: 147–148. pmid:12138068
View Article
PubMed/NCBI
Google Scholar

[63] View Article

[64] PubMed/NCBI

[65] Google Scholar

[ref20] 20. Marcinno A, Marnetto F, Valentino P, Martire S, Balbo A, Drago A, et al. Rituximab-induced hypogammaglobulinemia in patients with neuromyelitis optica spectrum disorders. Neurol Neuroimmunol Neuroinflamm. 2018;5: e498. pmid:30258855
View Article
PubMed/NCBI
Google Scholar

[67] View Article

[68] PubMed/NCBI

[69] Google Scholar

[ref21] 21. Mahmood I, Tegenge MA, Golding B. Considerations for optimizing dosing of immunoglobulins based on pharmacokinetic evidence. Antibodies (Basel). 2020;9. pmid:32575458
View Article
PubMed/NCBI
Google Scholar

[71] View Article

[72] PubMed/NCBI

[73] Google Scholar

[ref22] 22. Adams PC, Reboussin DM, Barton JC, McLaren CE, Eckfeldt JH, McLaren GD, et al. Hemochromatosis and iron-overload screening in a racially diverse population. N Engl J Med. 2005;352: 1769–1778. pmid:15858186
View Article
PubMed/NCBI
Google Scholar

[75] View Article

[76] PubMed/NCBI

[77] Google Scholar

[ref23] 23. Barton JC, Acton RT, Dawkins FW, Adams PC, Lovato L, Leiendecker-Foster C, et al. Initial screening transferrin saturation values, serum ferritin concentrations, and HFE genotypes in whites and blacks in the Hemochromatosis and Iron Overload Screening Study. Genet Test. 2005;9: 231–241.
View Article
Google Scholar

[79] View Article

[80] Google Scholar

[ref24] 24. Barton JC, Barton JC, Acton RT. HLA-A*03, the hemochromatosis ancestral haplotype, and phenotypes of referred hemochromatosis probands with HFE p.C282Y homozygosity. Hereditas. 2022;159: 25.
View Article
Google Scholar

[82] View Article

[83] Google Scholar

[ref25] 25. Barton JC, Acton RT. HLA-A and -B alleles and haplotypes in hemochromatosis probands with HFE C282Y homozygosity in central Alabama. BMC Med Genet. 2002;3: 9.
View Article
Google Scholar

[85] View Article

[86] Google Scholar

[ref26] 26. Barton JC, Bertoli LF, Acton RT. HLA-A and -B alleles and haplotypes in 240 index patients with common variable immunodeficiency and selective IgG subclass deficiency in central Alabama. BMC Med Genet. 2003;4: 3. pmid:12803653
View Article
PubMed/NCBI
Google Scholar

[88] View Article

[89] PubMed/NCBI

[90] Google Scholar

[ref27] 27. Johnston DT, Mehaffey G, Thomas J, Young KR Jr., Wiener H, Li J, et al. Increased frequency of HLA-B44 in recurrent sinopulmonary infections (RESPI). Clin Immunol. 2006;119: 346–350. pmid:16542878
View Article
PubMed/NCBI
Google Scholar

[92] View Article

[93] PubMed/NCBI

[94] Google Scholar

[ref28] 28. Adams PC, Barton JC. How I treat hemochromatosis. Blood. 2010;116: 317–325. pmid:20308595
View Article
PubMed/NCBI
Google Scholar

[96] View Article

[97] PubMed/NCBI

[98] Google Scholar

[ref29] 29. Barton JC, Barton JC, Bertoli LF, Acton RT. Dataset: IgG subclasses in 157 referred hemochromatosis probands with HFE p.C282Y homozygosity; 6-24-2023 [cited 6-24-2023]. https://figshare.com/account/items/23574933/edit

[ref30] 30. Vidarsson G, Dekkers G, Rispens T. IgG subclasses and allotypes: from structure to effector functions. Front Immunol. 2014;5: 520. pmid:25368619
View Article
PubMed/NCBI
Google Scholar

[101] View Article

[102] PubMed/NCBI

[103] Google Scholar

[ref31] 31. Barton JC, Barton JC, Bertoli LF, Acton RT. Factors associated with IgG levels in adults with IgG subclass deficiency. BMC Immunol. 2021;22: 53. pmid:34372773
View Article
PubMed/NCBI
Google Scholar

[105] View Article

[106] PubMed/NCBI

[107] Google Scholar

[ref32] 32. Morrell A, Skvaril F, Steinberg AG, van Loghem E, Terry WD. Correlations between the concentrations of the four sub-classes of IgG and Gm allotypes in normal human sera. J Immunol. 2023;108: 195–206.
View Article
Google Scholar

[109] View Article

[110] Google Scholar

[ref33] 33. van der Giessen M, Rossouw E, van Veen TA, van L E, Zegers BJ, Sander PC. Quantification of IgG subclasses in sera of normal adults and healthy children between 4 and 12 years of age. Clin Exp Immunol. 1975;21: 501–509. pmid:54236
View Article
PubMed/NCBI
Google Scholar

[112] View Article

[113] PubMed/NCBI

[114] Google Scholar

[ref34] 34. Shakib F, Stanworth DR, Drew R, Catty D. A quantitative study of the distribution of IgG sub-classes in a group of normal human sera. J Immunol Methods. 1975;8: 17–28. pmid:807655
View Article
PubMed/NCBI
Google Scholar

[116] View Article

[117] PubMed/NCBI

[118] Google Scholar

[ref35] 35. French MA, Harrison G. Serum IgG subclass concentrations in healthy adults: a study using monoclonal antisera. Clin Exp Immunol. 1984;56: 473–475. pmid:6733979
View Article
PubMed/NCBI
Google Scholar

[120] View Article

[121] PubMed/NCBI

[122] Google Scholar

[ref36] 36. Aucouturier P, Mounir S, Preud’homme JL. Distribution of IgG subclass levels in normal adult sera as determined by a competitive enzyme immunoassay using monoclonal antibodies. Diagn Immunol. 1985;3: 191–196. pmid:4085174
View Article
PubMed/NCBI
Google Scholar

[124] View Article

[125] PubMed/NCBI

[126] Google Scholar

[ref37] 37. Madassery JV, Kwon OH, Lee SY, Nahm MH. IgG2 subclass deficiency: IgG subclass assays and IgG2 concentrations among 8015 blood donors. Clin Chem. 1988;34: 1407–1413. pmid:3292083
View Article
PubMed/NCBI
Google Scholar

[128] View Article

[129] PubMed/NCBI

[130] Google Scholar

[ref38] 38. Schauer U, Stemberg F, Rieger CH, Borte M, Schubert S, Riedel F, et al. IgG subclass concentrations in certified reference material 470 and reference values for children and adults determined with the binding site reagents. Clin Chem. 2003;49: 1924–1929. pmid:14578325
View Article
PubMed/NCBI
Google Scholar

[132] View Article

[133] PubMed/NCBI

[134] Google Scholar

[ref39] 39. Harkness T, Fu X, Zhang Y, Choi HK, Stone JH, Blumenthal KG, et al. Immunoglobulin G and immunoglobulin G subclass concentrations differ according to sex and race. Ann Allergy Asthma Immunol. 2020;125: 190–195. pmid:32224206
View Article
PubMed/NCBI
Google Scholar

[136] View Article

[137] PubMed/NCBI

[138] Google Scholar

[ref40] 40. Sadeghian MH, Keramati MR, Ayatollahi H, Manavifar L, Enaiati H, Mahmoudi M. Serum immunoglobulins in patients with iron deficiency anemia. Indian J Hematol Blood Transfus. 2010;26: 45–48. pmid:21629635
View Article
PubMed/NCBI
Google Scholar

[140] View Article

[141] PubMed/NCBI

[142] Google Scholar

[ref41] 41. Feng XB, Yang XQ, Shen J. Influence of iron deficiency on serum IgG subclass and pneumococcal polysaccharides specific IgG subclass antibodies. Chin Med J (Engl). 1994;107: 813–816. pmid:7867386
View Article
PubMed/NCBI
Google Scholar

[144] View Article

[145] PubMed/NCBI

[146] Google Scholar

[ref42] 42. Bashirova AA, Zheng W, Akdag M, Augusto DG, Vince N, Dong KL, et al. Population-specific diversity of the immunoglobulin constant heavy G chain (IGHG) genes. Genes Immun. 2021;22: 327–334. pmid:34864821
View Article
PubMed/NCBI
Google Scholar

[148] View Article

[149] PubMed/NCBI

[150] Google Scholar

[ref43] 43. Ferrante A, Beard LJ, Feldman RG. IgG subclass distribution of antibodies to bacterial and viral antigens. Pediatr Infect Dis J. 1990;9: S16–S24. pmid:2216603
View Article
PubMed/NCBI
Google Scholar

[152] View Article

[153] PubMed/NCBI

[154] Google Scholar

[ref44] 44. Morell A, Skvaril F, Steinberg AG, van L E, Terry WD. Correlations between the concentrations of the four sub-classes of IgG and Gm allotypes in normal human sera. J Immunol. 1972;108: 195–206. pmid:4622006
View Article
PubMed/NCBI
Google Scholar

[156] View Article

[157] PubMed/NCBI

[158] Google Scholar

[ref45] 45. Khokar A, Gupta S. Clinical and immunological features of 78 adult patients with primary selective IgG subclass deficiencies. Arch Immunol Ther Exp (Warsz). 2019;67: 325–334. pmid:31363786
View Article
PubMed/NCBI
Google Scholar

[160] View Article

[161] PubMed/NCBI

[162] Google Scholar

[ref46] 46. Latiff AH, Kerr MA. The clinical significance of immunoglobulin A deficiency. Ann Clin Biochem. 2007;44: 131–139. pmid:17362578
View Article
PubMed/NCBI
Google Scholar

[164] View Article

[165] PubMed/NCBI

[166] Google Scholar

[ref47] 47. Costa M, Cruz E, Barton JC, Thorstensen K, Morais S, da Silva BM, et al. Effects of highly conserved major histocompatibility complex (MHC) extended haplotypes on iron and low CD8+ T lymphocyte phenotypes in HFE C282Y homozygous hemochromatosis patients from three geographically distant areas. PLoS One. 2013;8: e79990.
View Article
Google Scholar

[168] View Article

[169] Google Scholar

[ref48] 48. Barton JC, Barton JC, Cruz E, Teles MJ, Guimaraes JT, Porto G. Chromosome 6p SNP microhaplotypes and IgG3 levels in hemochromatosis probands with HFE p.C282Y homozygosity. Blood Cells Mol Dis. 2020;85: 102461.
View Article
Google Scholar

[171] View Article

[172] Google Scholar

[ref49] 49. National Human Genome Research Institute and European Bioinformatics Institute. GWAS Catalog. The NHGRI-EBI Catalog of human genome-wide association studies; 5-20-2023 [cited 6-2-2023]. https://www.ebi.ac.uk/gwas/search?query

[ref50] 50. proteinatlas.org. The Human Protein Atlas. HFE; 2023 [cited 6-23-2023]. https://www.proteinatlas.org/ENSG00000010704-HFE

Figures

Abstract

Background

Methods

Results

Conclusions

Introduction

Methods

Ethics statement

Subjects included

Subjects excluded

Laboratory

Iron removed to achieve iron depletion

IgG subclasses in previously reported adult cohorts

Statistics

Results

Validation of a replicate hemochromatosis proband cohort

Characteristics of 157 referred hemochromatosis probands

Frequency distributions of IgG subclass levels

Percentiles of IgG subclass levels

Correlations of IgG subclass levels

IgG subclass levels of adults with and without hemochromatosis diagnoses

Discussion

Conclusions

References